Investors in Phreesia, Inc. are facing a July 13, 2026 deadline to seek appointment as lead plaintiff in a securities class action lawsuit. Pomerantz LLP reminds purchasers of the company's common stock between May 8, 2025, and March 30, 2026, inclusive, of the upcoming deadline. The lawsuit alleges that defendants made false and misleading statements regarding the company's business and financial outlook, specifically concealing deteriorating demand and reduced visibility in its Network Solutions segment and overstating the benefits of the AccessOne acquisition.

Allegations and Core Claims

The complaint asserts that Phreesia failed to disclose that pharmaceutical marketing commitments within its Network Solutions segment were weakening and that the company was experiencing reduced visibility into future spending commitments from pharmaceutical manufacturers. Defendants provided positive statements while concealing material adverse facts concerning the true state of Phreesia's slowing demand. Network Solutions clients were committing lower spending levels for the second half of fiscal year 2027 than anticipated, and increasing variability in revenue forecasting placed the company's fiscal year 2027 revenue guidance and long-term growth outlook at risk.

Guidance Revision and Market Reaction

On March 30, 2026, Phreesia announced significantly reduced revenue growth projections for fiscal year 2027. The company cut its guidance to $510 million to $520 million, a reduction of up to $49 million from the prior range of $545 million to $559 million issued on December 8, 2025. The company attributed the shortfall to "shorter visibility into spending commitments" from certain pharmaceutical manufacturers and weaker pharmaceutical marketing commitments. On this news, Phreesia's stock price fell approximately 27%, declining from a closing price of $11.41 per share on March 30, 2026, to $8.38 per share on March 31, 2026.

The following table contrasts the fiscal 2027 projections made in December 2025 with the revised figures issued in March 2026:

Class Period and Deadlines

The relevant dates for the securities class action are outlined below:

How to Participate

To join the Phreesia class action or to serve as lead plaintiff, investors must move the Court no later than July 13, 2026. Investors may contact Danielle Peyton at Pomerantz LLP at newaction@pomlaw.com or 646-581-9980, toll-free at 888.4-POMLAW, Ext. 7980. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Investors may also remain an absent class member, and eligibility to recover losses is based on purchase dates during the class period, not on current share ownership.